Table 3.

Multivariate predictors in the Cox proportional-hazards model.

	HR (95% CI)	p-value
In-hospital mortality
Q4 vs. Q1–Q3	2.751 (1.349–5.612)	0.005
1-vessel disease		0.919
2-vessel disease	1.162 (0.512–2.637)	0.719
3-vessel disease	1.01 (0.439–2.323)	0.981
Smoking	1.754 (0.841–3.656)	0.134
STEMI vs. NSTEMI	1.953 (0.802–4.755)	0.14
Age	1.011 (0.974–1.049)	0.574
eGFR	0.966 (0.949–0.983)	<0.01
Heart failure	0.408 (0.167–0.998)	0.049
Diabetes	1.722 (0.81–3.663)	0.158
Shock	14.429 (6.864–30.334)	<0.01
30-day mortality
Q4 vs. Q1–Q3	2.531 (1.23–5.205)	0.012
1-vessel disease		0.664
2-vessel disease	1.483 (0.632–3.482)	0.365
3-vessel disease	1.253 (0.531–2.959)	0.606
Smoking	1.932 (0.919–4.062)	0.082
STEMI vs. NSTEMI	1.827 (0.746–4.478)	0.187
Age	1.012 (0.974–1.051)	0.55
eGFR	0.962 (0.945–0.98)	<0.01
Heart failure	0.394 (0.153–1.015)	0.054
Diabetes	1.543 (0.715–3.332)	0.269
Shock	11.798 (5.606–24.833)	<0.01
1-year mortality
Q4 vs. Q1–Q3	1.726 (1.024–2.907)	0.04
1-vessel disease		0.81
2-vessel disease	1.013 (0.552–1.856)	0.968
3-vessel disease	1.2 (0.653–2.204)	0.557
Smoking	1.146 (0.64–2.053)	0.646
STEMI vs. NSTEMI	1.082 (0.613–1.911)	0.786
Age	1.035 (1.004–1.066)	0.026
eGFR	0.979 (0.966–0.992)	0.002
Heart failure	0.673 (0.351–1.292)	0.234
Diabetes	1.262 (0.697–2.283)	0.442
Shock	12.409 (7.164–21.494)	<0.01
Atrial fibrillation	0.495 (0.214–1.144)	0.1
30-day to 1-year landmark analysis
Q4 vs. Q1–Q3	1.206 (0.547–2.656)	0.642
Smoking	0.633 (0.24–1.673)	0.357
STEMI vs. NSTEMI	0.767 (0.356–1.656)	0.5
Age	1.083 (1.034–1.135)	0.001
eGFR	1.007 (0.989–1.026)	0.438
Heart failure	1.413 (0.554–3.603)	0.469
Diabetes	0.785 (0.313–1.966)	0.605
Shock	8.951 (3.85–20.81)	<0.01
Atrial fibrillation	1.399 (0.496–3.948)	0.526

eGFR, estimated glomerular filtration rate; NSTEMI, non-ST-elevation myocardial infarction; STEMI, ST-elevation myocardial infarction.